AB Science S.A. (LON:0Q77)
1.342
-0.086 (-6.02%)
At close: Feb 11, 2026
AB Science Employees
AB Science had 36 employees as of June 30, 2025. The number of employees decreased by 3 or -7.69% since the number was reported on December 31, 2024.
Employees
36
Change
-3
Growth
-7.69%
Revenue / Employee
24.45K GBP
Profits / Employee
-203.32K GBP
Market Cap
84.52M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Jun 30, 2025 | 36 | -3 | -7.69% | 36 | 0 |
| Dec 31, 2024 | 39 | -18 | -31.58% | 28 | 11 |
| Dec 31, 2023 | 57 | -46 | -44.66% | 51 | 6 |
| Dec 31, 2022 | 103 | 5 | 5.10% | 103 | 0 |
| Dec 31, 2021 | 98 | 6 | 6.52% | 98 | 0 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
Related Stocks
| Company Name | Employees |
|---|---|
| AstraZeneca | 94,300 |
| GSK plc | 68,629 |
| Haleon | 24,561 |
| Smith & Nephew | 17,000 |
| INSPECS Group | 1,654 |
| EKF Diagnostics Holdings | 297 |
| ECO Animal Health Group | 200 |
| Creo Medical Group | 129 |
AB Science News
- 21 days ago - Investor AB GAAP EPS of SEK 18.09, revenue of SEK 16.79B - Seeking Alpha
- 2 months ago - AllianceBernstein Holding L.P. Limited Partnership Units (AB) Presents at Goldman Sachs 2025 U.S. Financial Services Conference Transcript - Seeking Alpha
- 3 months ago - Bitcoin Rebounds To $93,000 As Ethereum, XRP, Dogecoin Rise 3% - Benzinga
- 3 months ago - Bitcoin Slips Below $102,000 As Ethereum, XRP, Dogecoin Drop Over 2% - Benzinga
- 3 months ago - Q3 2025 Fingerprint Cards AB Earnings Call Transcript - GuruFocus
- 3 months ago - The AI Boom: Bubble Or Bonanza? - Seeking Alpha
- 4 months ago - AB Science S.A. (ABSCF) Discusses Clinical Update on AB8939 Combined With Venetoclax for Refractory and Relapsed AML With Poor Genetics Transcript - Seeking Alpha
- 6 months ago - Market concentration is scary and it's all around AI, says AB's Jim Tierney - CNBC